Pappalysin-1, Pregnancy-associated plasma protein A, PAPP-A, IGF-dependent IGFBP-4 protease, IGFBP-4ase, PAPPA, PAPA, DIPLA1, PAPPA1, ASBABP2.
PAPP-A Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 191 amino acids fragment (81-271) corresponding to the PAPP-A “Jelly-Roll” domain fragment, having a total molecular mass of 25.75kDa and fused with an amino-terminal hexahistidine tag.
The PAPP-A is purified by proprietary chromatographic techniques.
This product consists of the recombinant PAPP-A 'Jelly-Roll' domain (amino acids 81-271) produced in E. coli. It is a non-glycosylated polypeptide chain with an amino-terminal hexahistidine tag, resulting in a molecular mass of 25.75 kDa. The protein is purified using proprietary chromatographic techniques.
The PAPP-A protein is supplied in a buffer consisting of 20mM Tris-HCl (pH 8.0), 4M Urea, and 50% Glycerol.
Pappalysin-1, Pregnancy-associated plasma protein A, PAPP-A, IGF-dependent IGFBP-4 protease, IGFBP-4ase, PAPPA, PAPA, DIPLA1, PAPPA1, ASBABP2.
PAPP-A is widely used in prenatal screening tests for Down syndrome . Low levels of PAPP-A in maternal serum during the first trimester are associated with an increased risk of chromosomal abnormalities, including Down syndrome . Additionally, low PAPP-A levels can indicate potential complications with the placenta, such as intrauterine growth restriction, preeclampsia, placental abruption, premature birth, or fetal death .